Biogen Idec (Nasdaq: BIIB) and Elan Corp (NYSE: ELN) announced that findings from their safety evaluation of TYSABRI in patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE